Abstract SUBMISSION topics

01. Genomics, genetic basis of disease and functional genomics

02. Adaptive immunity (T cells and B cells) in rheumatic diseases

03. Innate immunity in rheumatic diseases

04. Osteo arthritis, aetiology, pathology and animal models

05. Bone diseases, aetiology, pathology and animal models

06. Rheumatoid arthritis - aetiology, pathogenesis and animal models

07. Spondyloarthritis - aetiology, pathogenesis and animal models

08. SLE, Sjögren’s and APS - aetiology, pathogenesis and animal models

09. Systemic sclerosis, myositis and related syndromes - aetiology, pathogenesis and animal models

10. Vasculitis - aetiology, pathogenesis and animal models

11. Basic and translational science in paediatric rheumatology

12. Basic and translational pain science

13. Rheumatoid arthritis - prognosis, predictors and outcome

14. Rheumatoid arthritis - comorbidity and clinical aspects

15. Rheumatoid arthritis - biological DMARDs

16. Rheumatoid arthritis - non biologic treatment and small molecules

17. SLE, Sjögren’s and APS – treatment

18. SLE, Sjögren’s and APS - clinical aspects (other than treatment)

19. Vasculitis – large vessel vasculitis

20. Vasculitis – small vessel vasculitis

21. Scleroderma, myositis and related syndromes

22. Spondyloarthritis – treatment

23. Spondyloarthritis - clinical aspects (other than treatment)

24. Psoriatic arthritis – treatment

25. Psoriatic arthritis - clinical aspects (other than treatment)

26. Osteoarthritis

27. Osteoporosis

28. Crystal diseases, metabolic bone diseases other than osteoporosis

29. Infection-related rheumatic diseases

30. COVID-19

31. Pain in rheumatic diseases, including fibromyalgia

32. Spine, mechanical musculoskeletal problems, local soft tissue disorders

33. Paediatric rheumatology

34. Other orphan diseases

35. Diagnostics and imaging procedures

36. Public health, health services research, and health economics

37. Epidemiology, risk factors for disease or disease progression

38. Validation of outcome measures and biomarkers

39. Rehabilitation

40. Education

41. Educational cases

42. HPR Measuring health (development and measurement properties of PROs, tests, devices)

43. HPR Epidemiology and public health (including prevention)

44. HPR Interventions (educational, physical, social and psychological)

45. HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)

46. HPR Service developments, innovation and economics in healthcare

47. HPR Professional education, training and competencies

48. HPR Interdisciplinary research

49. Patient information and education

50. Building patient led organisations

51. Arthritis research

52. Innovations in arthritis health care

53. Psychosocial support

54. Work and rehabilitation

55. Best practice campaigning